<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font23 { font-size : 23; } .font25 { font-size : 25; } .font28 { font-size : 28; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">patients </span>
   <span class="font28">COVID- </span>
   <span class="font25">[]. </span>
   <span class="font23">vs. </span>
   <span class="font18">myocardial </span>
   <span class="font17">acute </span>
   <span class="font16">severe </span>
   <span class="font15">respiratory </span>
   <span class="font14">injury </span>
   <span class="font14">[,]. </span>
   <span class="font14">disease </span>
   <span class="font14">coronavirus </span>
   <span class="font14">(.%) </span>
   <span class="font14">viral </span>
   <span class="font13">cardiac </span>
   <span class="font13">heart </span>
   <span class="font13">{border-style </span>
   <span class="font13">CVD </span>
   <span class="font13">ACE </span>
   <span class="font13">Cardiovascular </span>
   <span class="font13">Disease </span>
   <span class="font13">associated </span>
   <span class="font13">increased </span>
   <span class="font13">infection </span>
   <span class="font13">px;} </span>
   <span class="font13">risk </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">(%)% </span>
   <span class="font13">(.%).% </span>
   <span class="font13">SARS-CoV- </span>
   <span class="font13">Patients </span>
   <span class="font12">(%) </span>
   <span class="font12">cardiovascular </span>
   <span class="font12">clinical </span>
   <span class="font12">including </span>
   <span class="font12">COVID-, </span>
   <span class="font12">SARS </span>
   <span class="font12">studies </span>
   <span class="font12">study </span>
   <span class="font12">syndrome </span>
   <span class="font12">Heart </span>
   <span class="font12">cases </span>
   <span class="font12">common </span>
   <span class="font12">reported </span>
   <span class="font12">cohort </span>
   <span class="font12">higher </span>
   <span class="font12">(.% </span>
   <span class="font12">(â€") </span>
   <span class="font12">ECMO </span>
   <span class="font12">However, </span>
   <span class="font12">case </span>
   <span class="font12">enzyme </span>
   <span class="font11">RAAS </span>
   <span class="font11">Wuhan, </span>
   <span class="font11">data </span>
   <span class="font11">failure </span>
   <span class="font11">influenza </span>
   <span class="font11">mortality </span>
   <span class="font11">potential </span>
   <span class="font11">pulmonary </span>
   <span class="font11">(Lond. </span>
   <span class="font11">Coronavirus </span>
   <span class="font11">Engl. </span>
   <span class="font11">Engl.)./S-()- </span>
   <span class="font11">evidence </span>
   <span class="font11">increase </span>
   <span class="font11">lung </span>
   <span class="font11">myocarditis </span>
   <span class="font11">online: </span>
   <span class="font11">pre-existing </span>
   <span class="font11">rate </span>
   <span class="font11">recent </span>
   <span class="font11">&amp;lt; </span>
   <span class="font11">(COVID-) </span>
   <span class="font11">April </span>
   <span class="font11">COVID-. </span>
   <span class="font11">China </span>
   <span class="font11">al.Clinical </span>
   <span class="font11">cause </span>
   <span class="font11">demonstrated </span>
   <span class="font11">novel </span>
   <span class="font11">number </span>
   <span class="font11">observed </span>
   <span class="font11">patients, </span>
   <span class="font11">pneumonia </span>
   <span class="font11">px; </span>
   <span class="font11">underlying </span>
   <span class="font11">{font-family </span>
   <span class="font11">.collab: </span>
   <span class="font11">ARDS </span>
   <span class="font11">Myocardial </span>
   <span class="font11">angiotensin </span>
   <span class="font11">angiotensin-converting </span>
   <span class="font11">available </span>
   <span class="font11">care </span>
   <span class="font11">complications </span>
   <span class="font11">critical </span>
   <span class="font11">effects </span>
   <span class="font11">fatality </span>
   <span class="font11">font-size </span>
   <span class="font11">high </span>
   <span class="font11">hospitalized </span>
   <span class="font11">immune </span>
   <span class="font11">incidence </span>
   <span class="font11">inflammatory </span>
   <span class="font11">inhibitors </span>
   <span class="font11">levels </span>
   <span class="font11">patient </span>
   <span class="font11">receptor </span>
   <span class="font11">retrospective </span>
   <span class="font11">similar </span>
   <span class="font11">treatment </span>
   <span class="font11">troponin </span>
   <span class="font11">.), </span>
   <span class="font11">Acute </span>
   <span class="font11">CAD </span>
   <span class="font11">J../eurheartj/ehaa </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">[,], </span>
   <span class="font11">activity </span>
   <span class="font11">admission </span>
   <span class="font11">adverse </span>
   <span class="font11">coagulopathy </span>
   <span class="font11">considered </span>
   <span class="font11">double; </span>
   <span class="font11">drug </span>
   <span class="font11">elevated </span>
   <span class="font11">human </span>
   <span class="font11">inflammation </span>
   <span class="font11">oxygen </span>
   <span class="font11">present </span>
   <span class="font11">prevalence </span>
   <span class="font11">reports </span>
   <span class="font11">review </span>
   <span class="font11">role </span>
   <span class="font11">suggested </span>
   <span class="font11">ventricular </span>
   <span class="font11">virus </span>
   <span class="font10">(%), </span>
   <span class="font10">(.%), </span>
   <span class="font10">.%, </span>
   <span class="font10">Cardiac </span>
   <span class="font10">Clinical </span>
   <span class="font10">East </span>
   <span class="font10">Infect. </span>
   <span class="font10">MERS </span>
   <span class="font10">Middle </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Risk </span>
   <span class="font10">[,,]. </span>
   <span class="font10">abnormalities </span>
   <span class="font10">and/or </span>
   <span class="font10">animal </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cell </span>
   <span class="font10">coronary </span>
   <span class="font10">critically </span>
   <span class="font10">cytokine </span>
   <span class="font10">described </span>
   <span class="font10">disorders </span>
   <span class="font10">distress </span>
   <span class="font10">early </span>
   <span class="font10">hospitalization </span>
   <span class="font10">ill </span>
   <span class="font10">illness </span>
   <span class="font10">mainly </span>
   <span class="font10">median </span>
   <span class="font10">mild </span>
   <span class="font10">older </span>
   <span class="font10">remains </span>
   <span class="font10">response </span>
   <span class="font10">severity </span>
   <span class="font10">solid; </span>
   <span class="font10">suggesting </span>
   <span class="font10">survivors </span>
   <span class="font10">symptoms </span>
   <span class="font10">therapies </span>
   <span class="font10">thrombotic </span>
   <span class="font10">used </span>
   <span class="font10">years </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(.%)% </span>
   <span class="font10">.%), </span>
   <span class="font10">American </span>
   <span class="font10">Angiotensin </span>
   <span class="font10">Cardiol../jamacardio.. </span>
   <span class="font10">Characteristics </span>
   <span class="font10">China: </span>
   <span class="font10">College </span>
   <span class="font10">Health </span>
   <span class="font10">Hospitalized </span>
   <span class="font10">ICU </span>
   <span class="font10">Inhibitors </span>
   <span class="font10">Italy </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Management </span>
   <span class="font10">Med../NEJMoa </span>
   <span class="font10">New </span>
   <span class="font10">Non-ICU </span>
   <span class="font10">Potential </span>
   <span class="font10">RNA </span>
   <span class="font10">Respiratory </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">Severe </span>
   <span class="font10">Table </span>
   <span class="font10">VTE </span>
   <span class="font10">[]ICU </span>
   <span class="font10">al.A </span>
   <span class="font10">arrhythmia </span>
   <span class="font10">based </span>
   <span class="font10">bold </span>
   <span class="font10">cardiomyopathy </span>
   <span class="font10">cases, </span>
   <span class="font10">compared </span>
   <span class="font10">control </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">days, </span>
   <span class="font10">death </span>
   <span class="font10">detected </span>
   <span class="font10">disease, </span>
   <span class="font10">dysfunction </span>
   <span class="font10">em; </span>
   <span class="font10">embolism </span>
   <span class="font10">entry </span>
   <span class="font10">expression </span>
   <span class="font10">features </span>
   <span class="font10">function </span>
   <span class="font10">indicated </span>
   <span class="font10">infarction </span>
   <span class="font10">infected </span>
   <span class="font10">infections </span>
   <span class="font10">inhibition </span>
   <span class="font10">initial </span>
   <span class="font10">injury, </span>
   <span class="font10">large </span>
   <span class="font10">likely </span>
   <span class="font10">mechanism </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">monitoring </span>
   <span class="font10">nonsurvivors </span>
   <span class="font10">patients. </span>
   <span class="font10">previously </span>
   <span class="font10">protease </span>
   <span class="font10">protective </span>
   <span class="font10">pt;} </span>
   <span class="font10">recently, </span>
   <span class="font10">report </span>
   <span class="font10">serum </span>
   <span class="font10">significant </span>
   <span class="font10">small </span>
   <span class="font10">spread </span>
   <span class="font10">suggest </span>
   <span class="font10">systemic </span>
   <span class="font10">various </span>
  </p>
 </body>
</html>
